Reflections, Reconciliation & Repsychopathologization | Beyond Gender 2025 Year in Review
1 January 2026
law-and-policy
Stella O'Malley, Mia Hughes, and Dr Bret Alderman take stock of a pivotal year. From Trump's executive orders and the HHS report to the For Women Scotland ruling and the UK puberty-blockers trial, 2025 produced more institutional reckoning than any year before it. The episode's sharpest concept is "repsychopathologization" — the slow return of gender distress to psychological inquiry rather than identity affirmation. This review maps the fault lines: which institutions moved with the evidence, and which, like Canada's, chose to double down.
Year-in-review episodes often flatten everything into a list of events. This one does something different. Stella O'Malley, Mia Hughes, and Dr Bret Alderman use 2025 as raw material for a harder question: not just what happened, but what the pattern of events reveals about the institutions, ideologies, and psychological frameworks that have driven gender medicine for the past decade. The American dimension of 2025 was abrupt and politically charged. Executive orders from the Trump administration and a report from the Department of Health and Human Services signalled a sharp federal policy reversal. Whatever one thinks of the political context, the hosts treat these developments less as partisan wins or losses and more as data points in a longer argument about evidence — what happens when governments previously captured by affirmation-only ideology are suddenly required to justify their positions against a growing body of sceptical research. Across the Atlantic, the evidence came through different channels. The For Women Scotland ruling and the UK puberty-blockers trial represented institutional processes — courts and clinical reviews — arriving at conclusions that align more closely with precautionary science than with gender-identity advocacy. These were not political gestures; they were the kind of slow, grinding reckonings that any serious account of 2025 has to grapple with. The word in the episode title that carries the most weight is "repsychopathologization." It is deliberate and clinical: the gradual return of gender distress to the domain of psychological inquiry rather than identity affirmation. For years, framing gender dysphoria as a psychological condition was treated as inherently stigmatising. The concept of repsychopathologization asks whether removing it from that domain caused more harm than it prevented. This is not a call to shame anyone. It is a call to take suffering seriously enough to ask what is actually driving it, and whether surgical and pharmacological interventions offered to minors are the appropriate response. Canada functions in this episode as the counter-case: a jurisdiction that, even as the evidentiary ground has shifted elsewhere, has continued to consolidate affirmation-only approaches. The hosts examine this not as a puzzle but as an illustration of how institutions behave when ideology and professional identity become deeply entangled. Doubling down in the face of contrary evidence is not unusual in institutional history; understanding why it happens, and what eventually breaks the cycle, matters as much as recognising the places that changed course. Looking toward 2026, the conversation turns to what still needs to happen — in clinical practice, in regulatory oversight, in how therapists are trained and how parents are supported. The year-in-review format gives the three hosts room to step back from individual cases and think about trajectory. That longer view — what shifted, what remains broken, and what the evidence is actually pointing toward — is what sets this kind of analysis apart from the advocacy noise on either side.
